Defence Therapeutics (DTC.CN) traded down -2.5 % during a 24 hours period ending at 05:47 AM Central Europe on Tuesday 27th. One Defence Therapeutics stock can currently be bought for about CAD 0.42 on popular exchanges. Current supply of Defence Therapeutics stocks is 75.8 mn. Defence Therapeutics has a current market capitalization of CAD 29.6 mn and approximately CAD 9 k worth of Defence Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Defence Therapeutics has traded -17.02 % down. Simple moving average of last 200 days is at CAD 0.51. The highest price of past 52 weeks was recorded at CAD 0.93 on 12/03/2025. 52 weeks low was at CAD 0.34 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Gold (NVX.V) traded down -10 % and now trades at CAD 1. Gold has a market capitalisation of CAD 34.8 mn.
Vior Gold (VIO.V) traded flat 0 % and now trades at CAD 0.09. Vior Gold has a market capitalisation of CAD 35.4 mn.
Mundoro Capital (MUN.V) traded down -6.06 % and now trades at CAD 0.31. Mundoro Capital has a market capitalisation of CAD 34.9 mn.
Sona Nanotech (SONA.CN) traded up 7.55 % and now trades at CAD 0.26. Current market capitalisation for Sona Nanotech is CAD 35 mn.
Ianthus Capital (IAN.CN) traded flat 0 % and now trades at CAD 0.01. Current market capitalisation for Ianthus Capital is CAD 34.9 mn.
About Defence Therapeutics
Defence Therapeutics Inc. is a biotechnology company based in Canada that operates on the Canadian National Stock Exchange. The company is focused on developing innovative therapies for various diseases, including cancer and immune system-related conditions. Their mission is to transform patient outcomes by providing novel, targeted treatments that can effectively address these health issues.
